Links to other sites are provided as a convenience to the viewer.
Pfizer accepts no responsibility for the content of linked sites.
The ATNAA is a specially designed unit for self- or buddy-administration by military personnel. Atropine and pralidoxime chloride are administered sequentially to counteract organophosphorus nerve agents. While a victim can administer their own injection, a second or third injection might be needed and should be administered by a buddy.1
ATNAA is indicated for the treatment of poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults. ATNAA is intended for use by Military Personnel. If feasible and appropriate, advise service member that ATNAA is an initial emergency treatment, that they need additional care at a healthcare facility.
This product is only available for use by United States military personnel.
|Key Product Specifications2:|
|Delivers||2.1 mg atropine in 0.7 mL and 600 mg pralidoxime chloride in 2 mL sequentially through a single needle using the two-chambered BinaJect® drug delivery system.|
|Length of Unit||145 mm|
|Diameter of Unit||19 mm|
|Needle Length||21 mm|
|Administration Type||Intramuscular injection|
|Packaged||100 auto-injectors per box|
|Packaging for Shipping||
100 units per box
2 interior boxes (200 units) per shipper box
|Storage||Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [See USP Controlled Room Temperature]. Keep from freezing. Protect from light.|
Adverse Event or Product Quality Complaints
If you wish to report an adverse event or product quality complaint, please call 1-800-438-1985.
For medical questions concerning Meridian products, to report an adverse event, or to speak to a member of Pfizer US Medical Information, please call 1-800-438-1985.